FWM
AYTU icon

Focused Wealth Management’s AYTU BioPharma AYTU Stock Holding History

Focused Wealth Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60
Closed – – 1095
2022
Q3 		$0 Buy
60
+50
+500% +$379 ﹤0.01% 943
2022
Q2 		$0 Hold
10
– – ﹤0.01% 924
2022
Q1 		$0 Hold
10
– – ﹤0.01% 987
2021
Q4 		$0 Hold
10
– – ﹤0.01% 981
2021
Q3 		$1K Hold
10
– – ﹤0.01% 864
2021
Q2 		$1K Hold
10
– – ﹤0.01% 855
2021
Q1 		$2K Buy
10
+6
+150% +$952 ﹤0.01% 791
2020
Q4 		$0 Hold
4
– – ﹤0.01% 814
2020
Q3 		$1K Buy
4
+2
+100% +$514 ﹤0.01% 719
2020
Q2 		$1K Buy
+2
New +$606 ﹤0.01% 708

Other funds holding AYTU

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Focused Wealth Management's AYTU Position: Q4 2022 in Review

Focused Wealth Management sold out of AYTU BioPharma (AYTU) in Q4 2022, closing a stake of 60 shares.

Focused Wealth Management first reported a position in AYTU in Q2 2020 and held it in 10 quarters. The position peaked at $2K in Q1 2021. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

  • Focused Wealth Management reported no remaining AYTU BioPharma position as of Q4 2022 after selling out during the quarter.
  • Focused Wealth Management sold 60 AYTU BioPharma shares in Q4 2022.
  • Focused Wealth Management first reported a position in AYTU BioPharma in Q2 2020 and held it in 10 quarters.
  • Focused Wealth Management's AYTU BioPharma position peaked at $2K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on Focused Wealth Management's 13F filing for Q4 2022, filed 13 Jan 2023.